authors Hemati, Homa Nosrati, Marzieh Hasanzad, Mandana Rahmani, Parham Soroush Fariman, PharmD, MSc Sarabi, Mohadese Shirvani, Sepideh Sadeghipour, Parham Nikfar, Shekoufeh
Keywords Cardiovascular Disease Cost Effectiveness Economic Evaluation Heart Valve Pharmacoeconomics Pharmacogenomics Precision Medicine Quality-Adjusted Life Year Warfarin